Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants

Archives of Ophthalmology

Volumn 118, Issue 12, 2000, Pages 1666-1671

  Qian, Ying ^a   Dekaris, Iva ^a   Yamagami, Satoru ^a   Dana, M Reza ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR RECEPTOR;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; GENE REPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033662520     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.12.1666     Document Type: Article

References (50)

1. The Collaborative Corneal Transplantation Studies (CCTS): Effectiveness of histocompatibility matching in high-risk corneal transplantation
2. Role of tumor necrosis factor receptors TNFR-I (p55) and TNFR-II (p75) in corneal transplantation
3. Taming TNF: Strategies To restrain this proinflammatory cytokine
4. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor
5. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
6. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-α induced skin inflammation
7. The tumor necrosis factor ligand and receptor families
8. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-α after corneal transplantation
9. Cytokine mRNA expression during experimental corneal allograft rejection
10. Determinations of serum tumor necrosis factor alpha in corneal allografts
11. Cytokine expression during orthotopic corneal allograft rejection in mice
12. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection
13. TNF-α regulates corneal Langerhans cell migration
14. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis
15. Influence of a recombinant human soluble tumor necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice
16. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis
17. Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: Correlation of plasma levels with efficacy
18. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina
19. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis
20. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor
21. The paradoxical effect of tumor necrosis factor alpha (TNF-} in endotoxin-induced uveitis
22. Systemic antitumor necrosis factor antibody treatment exacerbates endotoxin-induced uvetis in the rat
23. Anti-tumor necrosis factor α serum prolongs heart allograft survival in rats
24. Anti-tumor necrosis factor antibody enhances allograft survival in rats
25. Chemokines: Chemotactic cytokines that mediate inflammation
26. Differential chemokine gene expression in corneal transplant rejection
27. Chemokines and T lymphocytes: More than an attraction
28. Topical interleukin 1 receptor antagonist promotes corneal transplant survival
29. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice
30. Orthotopic corneal transplantation in mice: Evidence that the immunogenetic rules of rejection do not apply
31. Indirect presentation of MHC antigens in transplantation
32. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction
33. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation
34. Chemokines, inflammation and the immune system
35. Isolation of human conjunctival mast cells and epithelial cells: Tumor necrosis factor-α from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells
36. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function
37. RANTES production in a conjunctival epithelial cell line
38. Human macrophage inflammatory protein-1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes
39. Reactive oxygen intermediates increase vascular endothlial growth factor expression in vitro and in vivo
40. Requirement of vascular integrin alpha v beta 3 for angiogenesis
41. Ocular surface residence times of artificial tear solutions
42. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca: A double masked clinical trial
43. Update on topical cyclosporin A: Background, immunology, and pharmacology
44. Oral immunisation as a strategy for enhancing corneal allograft survival
45. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate
46. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in 'high risk' eyes
47. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival
48. Topical interleukin 1 receptor antagonist promotes corneal transplant survival
49. Prolongation of corneal allograft survival by an interleukin-2-immunoglobulin fusion protein in mice
50. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation